Please Wait
Applying Filters...
menu
    • menu
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Ro-Sulfram-500 (USA)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    31/03/2026 Solara Active Pharma Sciences
    India
    		 SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai IN CEP 2019-197 - Rev 02 Disulfiram 2025-05-23 Valid Chemical 603
    31/03/2026 ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL
    Gabon
    		 ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL CEP 2022-090 - Rev 01 Disulfiram, Milled 2024-12-18 Valid Chemical 603
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.